Condition: Atopic Dermatitis · Sponsor: Bambusa Therapeutics
This is a Phase 1, randomized, blinded, placebo controlled, single ascending dose (SAD) study of BBT001 in healthy volunteers (HVs) and adult patients with moderate to severe Atopic Dermatitis (AD).
This description comes directly from the study's public registry record.
Tracy Ji · +86 18001322760 · tracy.ji@bambusatx.com
Always discuss trial participation with your own doctor first.
| The Second Hospital of Anhui Medical Univesity | Hefei, Anhui, China | Recruiting |
| The Second Affiliated Hospital of Wannan Medical College | Wuhu, Anhui, China | Not Yet Recruiting |
| Peking University People's Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Dermatology Hospital of Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The Second Xiangya Hospital of Central South University | Changsha, Hunan, China | Not Yet Recruiting |
| Wuxi Second People's Hospital | Wuxi, Jiangsu, China | Not Yet Recruiting |
| Jiangsu University Affiliated Hospital | Zhenjiang, Jiangsu, China | Not Yet Recruiting |
| Jiangxi Provincial Dermatology Hospital | Nanchang, Jiangxi, China | Not Yet Recruiting |
| Shandong Provincial Hospital for Skin Diseases | Jinan, Shandong, China | Not Yet Recruiting |
| Shanghai Dermatology Hospital | Shanghai, Shanghai Municipality, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07239947